VYVGART SC DIN 02562634
Health Canada record
| Active ingredient(s) | EFGARTIGIMOD ALFA 200 MG |
|---|---|
| Dosage form | Solution |
| Route | Subcutaneous |
| Schedule | SCHEDULE D; PRESCRIPTION |
| Class | Human |
| ATC | L04AL01 EFGARTIGIMOD ALFA |
| Original market date | 20-Jan-2026 |
| Current status date | 20-Jan-2026 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing EFGARTIGIMOD ALFA
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02541599 | VYVGART | ARGENX BV | Solution | EFGARTIGIMOD ALFA 20 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 36311 | 2025-11-03 | Supplement to a New Drug Submission (SNDS) | New route of administration, new presentation, new manufacturing site for the drug substance |